High glucose promotes nascent nephron apoptosis via NF-κB and p53 pathways

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 1, 2011, Pages

  Chen, Yun Wen ^a   Chenier, Isabelle ^a   Chang, Shiao Ying ^a   Tran, Stella ^a   Ingelfinger, Julie R ^b   Zhang, Shao Ling ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLUCOSE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PROTEIN P50; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYONAL TISSUE; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; KIDNEY; MATERNAL DIABETES MELLITUS; MESENCHYME CELL; MORPHOLOGY; MOUSE; NEPHRON; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSIENT TRANSFECTION;

EID: 78651328538     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00361.2010     Document Type: Article

References (54)

1. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61: 85-95, 2001. (Pubitemid 32149652)
2. Anochie IC, Eke F. Renal vein thrombosis in the neonate: a case report and review of the literature. J Natl Med Assoc 96: 1648-1652, 2004. (Pubitemid 39627653)
3. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772, 2001.
4. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111: e382-e387, 2003.
5. Baserga M, Hale MA, Ke X, Wang ZM, Yu X, Callaway CW, McKnight RA, Lane RH. Uteroplacental insufficiency increases p53 phosphorylation without triggering the p53-MDM2 functional circuit response in the IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 291: R412-R418, 2006.
6. Bertram JF. Counting in the kidney. Kidney Int 59: 792-796, 2001.
7. Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 57: 451-459, 2008.
8. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 71: 912-923, 2007.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001. (Pubitemid 34000785)
10. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
11. Burns TF, El-Deiry WS. The p53 pathway and apoptosis. J Cell Physiol 181: 231-239, 1999.
12. Chen YW, Chenier I, Tran S, Scotcher M, Chang SY, Zhang SL. Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr Nephrol 25: 1319-1329, 2010.
13. Chen YW, Liu F, Tran S, Zhu Y, Hebert MJ, Ingelfinger JR, Zhang SL. Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced Pax-2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney explants. Kidney Int 70: 1607-1615, 2006.
14. Chugh SS, Wallner EI, Kanwar YS. Renal development in high-glucose ambience and diabetic embryopathy. Semin Nephrol 23: 583-592, 2003.
15. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25: 6800-6816, 2006.
16. El-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357, 1998.
17. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
18. Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53: 166-172, 2004.
19. Gareskog M, Cederberg J, Eriksson UJ, Wentzel P. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos. Reprod Toxicol 23: 63-74, 2007.
20. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J, Varmus HE. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10: 836-850, 1996.
21. Goldenberg RL. Factors influencing perinatal outcomes. Ann NY Acad Sci 1038: 227-234, 2004.
22. Kang BP, Frencher S, Reddy V, Kessler A, Malhotra A, Meggs LG. High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 284: F455-F466, 2003. (Pubitemid 36227906)
23. Kanwar YS, Nayak B, Lin S, Akagi S, Xie P, Wada J, Chugh SS, Danesh FR. Hyperglycemia: its imminent effects on mammalian nephrogenesis. Pediatr Nephrol 20: 858-866, 2005.
24. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 265: 731-736, 1991.
25. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7: 73-82, 1971.
26. Liu F, Brezniceanu ML, Wei CC, Chenier I, Sachetelli S, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 19: 269-280, 2008. (Pubitemid 351240649)
27. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int 75: 156-166, 2009.
28. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, Filep JG, Ingelfinger JR, Chan JS. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int 75: 156-166, 2009.
29. Lynch SA, Wright C. Sirenomelia, limb reduction defects, cardiovascular malformation, renal agenesis in an infant born to a diabetic mother. Clin Dysmorphol 6: 75-80, 1997.
30. Magaton A, Gil FZ, Casarini DE, Cavanal MD, Gomes GN. Maternal diabetes mellitus - early consequences for the offspring. Pediatr Nephrol 22: 37-43, 2007.
31. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, Prieto L, Frias JL. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 78: 140-145, 1998.
32. Mehta A, Hussain K. Transient hyperinsulinism associated with macrosomia, hypertrophic obstructive cardiomyopathy, hepatomegaly, and nephromegaly. Arch Dis Child 88: 822-824, 2003.
33. Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 55: 1642-1650, 2006.
34. Mercurio F, Manning AM. NF-kappaB as a primary regulator of the stress response. Oncogene 18: 6163-6171, 1999.
35. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
36. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10: 157-167, 1999.
37. Moore TS, Warshark C. Diabetes mellitus and pregnancy. eMedicine.June 1, 2010.
38. Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51: 3532-3544, 2002.
39. Nielsen GL, Norgard B, Puho E, Rothman KJ, Sorensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med 22: 693-696, 2005. (Pubitemid 40805888)
40. Oh SM, Pyo CW, Kim Y, Choi SY. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 23: 8282-8291, 2004.
41. Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 13: 759-772, 2006.
42. Piscione TD, Rosenblum ND. The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation 70: 227-246, 2002.
43. Saifudeen Z, Dipp S, Stefkova J, Yao X, Lookabaugh S, El-Dahr SS. p53 regulates metanephric development. J Am Soc Nephrol 20: 2328-2337, 2009.
44. Samikkannu T, Thomas JJ, Bhat GJ, Wittman V, Thekkumkara TJ. Acute effect of high glucose on long-term cell growth: a role for transient glucose increase in proximal tubule cell injury. Am J Physiol Renal Physiol 291: F162-F175, 2006.
45. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A. Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 18: 796-804, 2003.
46. Soler NG, Walsh CH, Malins JM. Congenital malformations in infants of diabetic mothers. Q J Med 45: 303-313, 1976.
47. Starkey JM, Haidacher SJ, LeJeune WS, Zhang X, Tieu BC, Choudhary S, Brasier AR, Denner LA, Tilton RG. Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex. Diabetes 55: 1252-1259, 2006.
48. Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hebert MJ, Ingelfinger JR, Zhang SL. Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 19: 943-952, 2008.
49. Valerius MT, Patterson LT, Witte DP, Potter SS. Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation. Mech Dev 112: 219-232, 2002.
50. Woolf AS. Multiple causes of human kidney malformations. Arch Dis Child 77: 471-473, 1997.
51. Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 108: 644-650, 2006.
52. Yiu WH, Mead PA, Jun HS, Mansfield BC, Chou JY. Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab Invest 90: 620-629, 2010.
53. Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 18: 2105-2115, 2007.
54. Zhang SL, Chen YW, Tran S, Liu F, Nestoridi E, Hebert MJ, Ingelfinger JR. Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol 22: 813-824, 2007.